Biofrontera AG B8F.DE Stock
Biofrontera AG Price Chart
Biofrontera AG B8F.DE Financial and Trading Overview
| Biofrontera AG stock price | 0.34 EUR |
| Previous Close | 0.85 EUR |
| Open | 0.85 EUR |
| Bid | 0.83 EUR x 84600 |
| Ask | 0.89 EUR x 20000 |
| Day's Range | 0.85 - 0.88 EUR |
| 52 Week Range | 0.83 - 1.71 EUR |
| Volume | 3.87K EUR |
| Avg. Volume | 4.76K EUR |
| Market Cap | 56.8M EUR |
| Beta (5Y Monthly) | 0.888505 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.7 EUR |
B8F.DE Valuation Measures
| Enterprise Value | 54.4M EUR |
| Trailing P/E | N/A |
| Forward P/E | 17.4 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2746437 |
| Price/Book (mrq) | 3.2954545 |
| Enterprise Value/Revenue | 2.179 |
| Enterprise Value/EBITDA | -208.248 |
Trading Information
Biofrontera AG Stock Price History
| Beta (5Y Monthly) | 0.888505 |
| 52-Week Change | -33.96% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.71 EUR |
| 52 Week Low | 0.83 EUR |
| 50-Day Moving Average | 1.12 EUR |
| 200-Day Moving Average | 1.37 EUR |
B8F.DE Share Statistics
| Avg. Volume (3 month) | 4.76K EUR |
| Avg. Daily Volume (10-Days) | 12.84K EUR |
| Shares Outstanding | 63.81M |
| Float | 27.66M |
| Short Ratio | N/A |
| % Held by Insiders | 55.34% |
| % Held by Institutions | 11.64% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -78.25% |
| Operating Margin (ttm) | -1.70% |
| Gross Margin | 80.39% |
| EBITDA Margin | -1.046% |
Management Effectiveness
| Return on Assets (ttm) | -0.73% |
| Return on Equity (ttm) | -83.54% |
Income Statement
| Revenue (ttm) | 24.97M EUR |
| Revenue Per Share (ttm) | 0.41 EUR |
| Quarterly Revenue Growth (yoy) | -11.70% |
| Gross Profit (ttm) | 20.98M EUR |
| EBITDA | -261250 EUR |
| Net Income Avi to Common (ttm) | -19541000 EUR |
| Diluted EPS (ttm) | -0.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.29M EUR |
| Total Cash Per Share (mrq) | 0.05 EUR |
| Total Debt (mrq) | 1.42M EUR |
| Total Debt/Equity (mrq) | 8.42 EUR |
| Current Ratio (mrq) | 1.354 |
| Book Value Per Share (mrq) | 0.264 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Biofrontera AG
| Country | Germany |
| State | N/A |
| City | Leverkusen |
| Address | Hemmelrather Weg 201 |
| ZIP | 51377 |
| Phone | N/A |
| Website | https://www.biofrontera.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 108 |
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; and Belixos, a medical skin care series for irritated and sensitive skin. It has a collaboration and partnership agreement with Maruho Co., Ltd. The company was founded in 1997 and is headquartered in Leverkusen, Germany.
Q&A For Biofrontera AG Stock
What is a current B8F.DE stock price?
Biofrontera AG B8F.DE stock price today per share is 0.34 EUR.
How to purchase Biofrontera AG stock?
You can buy B8F.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biofrontera AG?
The stock symbol or ticker of Biofrontera AG is B8F.DE.
Which industry does the Biofrontera AG company belong to?
The Biofrontera AG industry is Drug Manufacturers-Specialty & Generic.
How many shares does Biofrontera AG have in circulation?
The max supply of Biofrontera AG shares is 63.81M.
What is Biofrontera AG Price to Earnings Ratio (PE Ratio)?
Biofrontera AG PE Ratio is now.
What was Biofrontera AG earnings per share over the trailing 12 months (TTM)?
Biofrontera AG EPS is -0.1 EUR over the trailing 12 months.
Which sector does the Biofrontera AG company belong to?
The Biofrontera AG sector is Healthcare.
Biofrontera AG B8F.DE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| PRIME ALL SH. TR PRIME | 7076.21 EUR 7735.25 USD |
-0.2
|
— — | 7051.99 EUR 7708.78 USD | 7173.11 EUR 7841.18 USD | — - | — — |
| DAXSEC.PHA.+HEALTHC.PR CXKPX | 1902.7 EUR 2079.91 USD |
-0.26
|
— — | 1902.7 EUR 2079.91 USD | 1902.7 EUR 2079.91 USD | — - | — — |
| TECHN. ALL SHARE TR TECALL | 3949.51 EUR 4317.35 USD |
-0.53
|
— — | 3945.97 EUR 4313.48 USD | 4023.76 EUR 4398.51 USD | — - | — — |
| DAXSEC.PHA.+HEALTHC.TR CXPPX | 3558.78 EUR 3890.23 USD |
-0.26
|
— — | 3552.84 EUR 3883.73 USD | 3620.75 EUR 3957.97 USD | — - | — — |
| TECHN. ALL SHARE PR TECALLP | 2957.51 EUR 3232.96 USD |
-0.53
|
— — | 2954.86 EUR 3230.06 USD | 3013.11 EUR 3293.74 USD | — - | — — |
- {{ link.label }} {{link}}